Related references
Note: Only part of the references are listed.The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study
Evrydiki Kravvariti et al.
AUTOIMMUNITY REVIEWS (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Shaobo Shi et al.
JAMA CARDIOLOGY (2020)
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
Ren Mao et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China
Dong Chen et al.
JAMA NETWORK OPEN (2020)
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
A. B. Cavalcanti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Efficacy and safety of current therapeutic options for COVID-19-lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
Han Zhong et al.
PHARMACOLOGICAL RESEARCH (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
How to perform a meta-analysis with R: a practical tutorial
Sara Balduzzi et al.
EVIDENCE-BASED MENTAL HEALTH (2019)
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
Clotilde Chatre et al.
DRUG SAFETY (2018)
Therapeutic and Transmission-Blocking Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
Jean Popovici et al.
EMERGING INFECTIOUS DISEASES (2018)
A Randomized Comparison of Chloroquine versus Dihydroartemisinin-Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam
Phung Duc Thuan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study)
Lotte Heimans et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial
P. H. de Jong et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus
Ricardo Alkmim Teixeira et al.
EUROPACE (2014)
Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
James R. O'Dell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial
Sarah R. Kingsbury et al.
TRIALS (2013)
A Randomized Comparative Effectiveness Study of Oral Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis The Treatment of Early Aggressive Rheumatoid Arthritis Trial
Larry W. Moreland et al.
ARTHRITIS AND RHEUMATISM (2012)
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
Ronald F. van Vollenhoven et al.
LANCET (2012)
Pitfalls in meta-analyses on adverse events reported from clinical trials
Han-Yao Huang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Outlier and influence diagnostics for meta-analysis
Wolfgang Viechtbauer et al.
RESEARCH SYNTHESIS METHODS (2010)
Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data
Jan O. Friedrich et al.
BMC MEDICAL RESEARCH METHODOLOGY (2007)
Dramatic response to chloroquine and mirtazapine for recalcitrant atopic dermatitis
Matthew J. Zirwas
DERMATITIS (2006)
Role of US military research programs in the development of US Food and Drug Administration - Approved antimalarial drugs
LW Kitchen et al.
CLINICAL INFECTIOUS DISEASES (2006)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Share Paper
